Menu
Kshitij is a cell and molecular biologist with a deep passion for inter-disciplinary science. He has over a decade of experience in in-vitro, in-cellulo and in-vivo modalities spanning cell, molecular, synthetic, onco-biology. As a Scientist in the Immune Cell Engineering team, within the mRNA programming group, at Strand he is a vital part of helping develop a unique mRNA-based cell therapy platform targeting and treating both hematological and solid cancers. Kshitij has an undergraduate degree in Biochemistry & Molecular biology from Boston University where he worked in Dr. Mikel Garcia-Marcos’s lab to uncover novel mechanisms and roles of cytoplasmic GEF’s and how they modulate G protein signaling during normal development and cancer progression. He earned his Ph.D. in Cell & Molecular Biology from the University of North Carolina, Chape Hill in the lab of Dr. Antonio L. Amelio. His Ph.D. research program was a broad endeavor during which time he published numerous authored and co-authored papers on drug screening, drug resistance, role of ECM in tumor metastasis, chemo-optogenetics, and identified and validated a novel pan-cancer relevant driver of tumor metastasis.
